Apr 26, 2025 • Motley Fool
SOMEWHAT-BULLISH
4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off
It's always a good time to buy solid dividend stocks, but considering the challenging economic environment, now might be a particularly opportune time. Dividend-paying companies tend to have strong underlying operations and are generally more resilient than their non-dividend-paying counterparts.
Apr 26, 2025 • Benzinga
NEUTRAL
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cerevel Therapeutics
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Significant Losses In Cerevel To Contact Him Directly To Discuss Their Options
Apr 25, 2025 • Motley Fool
BULLISH
Why AbbVie Stock Topped the Market Today
A pair of convincing quarterly earnings beats -- not to mention a profitability guidance raise -- made AbbVie ( NYSE: ABBV ) stock an investor darling on Friday. The pharmaceutical company's performance pushed its stock to a more than 3% gain on the day, well higher than the 0.6% bump of the ...
Apr 25, 2025 • Benzinga
SOMEWHAT-BULLISH
ROSEN, A TOP RANKED LAW FIRM, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE
NEW YORK, April 25, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds persons or entities that ( 1 ) sold or otherwise disposed of the publicly-traded common stock of Cerevel Therapeutics Holdings, Inc.
Apr 25, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
AbbVie Beats on Q1 Earnings & Sales, Raises '25 EPS View
ABBV's first-quarter earnings and sales beat estimates. The company raises its EPS guidance based on the strong sales performance of immunology drugs Rinvoq and Skyrizi.
Apr 25, 2025 • Benzinga
NEUTRAL
Lowey Dannenberg Notifies Cerevel Therapeutics Holdings, Inc. ( "Cerevel" or the "Company" ) ( NASDAQ: CERE ) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm
NEW YORK, April 25, 2025 ( GLOBE NEWSWIRE ) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Cerevel Therapeutics Holdings, Inc. ( "Cerevel" or the "Company" ) CERE for violations of the ...